Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Hodson

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Leukemia|October 21, 2018
Targeting MEK in vemurafenib-resistant hairy cell leukemiaRebecca Caeser, Grace Collord, Wen-Qing Yao, et al.
Nature Immunology|April 11, 2017
Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1Rebecca Newman, Helena Ahlfors, Alexander Saveliev, et al.
Life Science Alliance|July 28, 2025
Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiationPanagiota Vardaka, Ben Kemp, Sophie Stephenson, et al.
Plos Pathogens|April 15, 2024
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in miceJillian A Bristol, Scott E Nelson, Makoto Ohashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2020
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesisThomas Sommermann, Tomoharu Yasuda, Jonathan Ronen, et al.
Blood|January 20, 2026
DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and SurvivalGiorgia Chiodin, Dylan James Tatterton, Philip J Rock, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2016
Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2Daniel J Hodson, Arthur L Shaffer, Wenming Xiao, et al.
Nature Immunology|July 13, 2010
Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemiaDaniel J Hodson, Michelle L Janas, Alison Galloway, et al.
Science Immunology|October 31, 2025
RNA binding proteins control the G<sub>2</sub>-M checkpoint of the germinal center B cellFiamma Salerno, Alex J Whale, Louise S Matheson, et al.
Ejhaem|December 5, 2022
Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective studySimon J Bulley, Anna Santarsieri, Isabel C Lentell, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Leukemia|October 21, 2018
Targeting MEK in vemurafenib-resistant hairy cell leukemiaRebecca Caeser, Grace Collord, Wen-Qing Yao, et al.
Nature Immunology|April 11, 2017
Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1Rebecca Newman, Helena Ahlfors, Alexander Saveliev, et al.
Life Science Alliance|July 28, 2025
Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiationPanagiota Vardaka, Ben Kemp, Sophie Stephenson, et al.
Plos Pathogens|April 15, 2024
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in miceJillian A Bristol, Scott E Nelson, Makoto Ohashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2020
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesisThomas Sommermann, Tomoharu Yasuda, Jonathan Ronen, et al.
Blood|January 20, 2026
DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and SurvivalGiorgia Chiodin, Dylan James Tatterton, Philip J Rock, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2016
Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2Daniel J Hodson, Arthur L Shaffer, Wenming Xiao, et al.
Nature Immunology|July 13, 2010
Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemiaDaniel J Hodson, Michelle L Janas, Alison Galloway, et al.
Science Immunology|October 31, 2025
RNA binding proteins control the G<sub>2</sub>-M checkpoint of the germinal center B cellFiamma Salerno, Alex J Whale, Louise S Matheson, et al.
Ejhaem|December 5, 2022
Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective studySimon J Bulley, Anna Santarsieri, Isabel C Lentell, et al.
Pageof 6